FDA moves toward easing restrictions on certain peptides BioPharma Dive From 'Wolverine' healing claims to health warnings: The unregulated rise of peptides ABC7 Los Angeles The peptide problem: Hype is outrunning the evidence New: An FDA decision to place 19 peptides on the unsafe list was supported by numerous documented safety concerns, former officials said. Even though demand for peptide therapies has exploded since then, FDA takes first step in possible reversal of ban on some peptides The Washington Post The FDA has issued clear signals on BPC 157: it is not approved for human use in any form due to potential significant safety risks. This critical classification profoundly impacts research and